Cure® Mosquito-Borne Diseases Report Reveals Critical Disconnect Between Experts vs. Physicians and the Public
First-of-its-kind survey shows primary care physicians and public have low awareness, low concerns despite global surge in life-threatening mosquito-borne diseases lacking effective therapies or vaccines NEW YORK, Oct. 9, 2024 /PRNewswire/ — Cure®, a healthcare innovation campus in New York
" title="Ping An Health’s MSCI ESG Rating Elevates to “AA”
Pioneering Sustainable Development in the Healthcare Sector HONG KONG and SHANGHAI, Oct. 9, 2024 /PRNewswire/ — Ping An Healthcare and Technology Company Limited (“Ping An Good Doctor“, “Ping An Health”, or “the Company”, Stock Code: 1833.HK) is pleased to
Adding Vagus Nerve Stimulation to Training Sessions May Boost How Well Sounds Are Perceived
NEW YORK, Oct. 9, 2024 /PRNewswire/ — Just as a musician can train to more sharply distinguish subtle differences in pitch, mammals can improve their ability to interpret hearing, vision, and other senses with practice. This process, which is called perceptual learning, may be enhanced by acti
Circumference Group Acquires Majority Stake in Visionary Integration Professionals
Strategic Partnership to Accelerate Digital Transformation Solutions LITTLE ROCK, Ark., Oct. 9, 2024 /PRNewswire/ — Circumference Group, an operationally focused investment firm founded by Jeff Fox, in partnership with The Pritzker Organization (TPO) and Stephens Capital Partners, has acquire
Equifax Makes Differentiated Data Products Available on Google Cloud Analytics Hub and Marketplace
Company’s Expanded Partnership with Google Cloud Provides Real-time Access to Anonymized Data Insights for Faster Innovation ATLANTA, Oct. 9, 2024 /PRNewswire/ — Equifax® (NYSE: EFX) has expanded its partnership with Google Cloud to securely deliver anonymized, differentiated data asse
HYZON SECURES ISO 9001 CERTIFICATION FOR FUEL CELL MANUFACTURING, DESIGN, AND RESEARCH AND DEVELOPMENT STANDARDS
Announcement Coincides with Hyzon’s Start of Production (SOP) of its Innovative Single-Stack 200kW Fuel Cell System (FCS) BOLINGBROOK, Ill., Oct. 9, 2024 /PRNewswire/ — Hyzon (NASDAQ: HYZN) (“Hyzon” or the “Company”), a U.S.-based, high-performance, hydrogen fue
The American College of Medical Genetics and Genomics (ACMG) and the ACMG Foundation for Genetic and Genomic Medicine (ACMGF) Announce New Strategic Plans
BETHESDA, Md., Oct. 9, 2024 /PRNewswire/ — The American College of Medical Genetics and Genomics (ACMG), the national specialty society for medical geneticists, and the ACMG Foundation, a 501(c)(3) nonprofit organization dedicated to facilitating the integration of genetics and genomics into m
Nisun Pre-Announces $192.5 Million in Record Revenue for H1 2024, Showing 52% Year-Over-Year Growth
Well capitalized and profitable, the Company has no plans to raise capital SHANGHAI, Oct. 9, 2024 /PRNewswire/ — Nisun International Enterprise Development Group Co., Ltd (“Nisun International” or the “Company”) (Nasdaq: NISN), a technology and industry driven integrate
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results
WARSAW, Ind., Oct. 9, 2024 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Wednesday, October 30, 2024 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day
Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD)
Treatment with once-daily EFFEXOR® met primary and all secondary efficacy endpoints in outpatient adults with GAD EFFEXOR® was generally well tolerated, consistent with its known safety profile Pharmaceuticals and Medical Devices Agency (PMDA) submission targeted for 2025 PITTSBURGH and TOKYO, Oct
